PMID- 37161616 OWN - NLM STAT- MEDLINE DCOM- 20231023 LR - 20231023 IS - 1525-1594 (Electronic) IS - 0160-564X (Linking) VI - 47 IP - 9 DP - 2023 Sep TI - Percutaneous decannulation of venoarterial extracorporeal membrane oxygenation using the Manta vascular closure device: A systematic review and meta-analysis. PG - 1431-1441 LID - 10.1111/aor.14554 [doi] AB - OBJECTIVES: To perform a systematic review and meta-analysis of the techniques and outcomes associated with percutaneous decannulation of venoarterial extracorporeal membrane oxygenation (VA-ECMO) using the Manta vascular closure device. BACKGROUND: Peripheral VA-ECMO can be used to treat critically ill patients with conditions such as refractory cardiogenic shock. After percutaneous implantation of VA-ECMO, VA-ECMO can also be decannulated completely percutaneously by using a vascular closure device. The Manta vascular closure device is a dedicated device used in the closure of large-bore arteriotomies by sandwiching the arteriotomy with an intra-arterial toggle and an extraluminal collagen plug. METHODS: We performed a thorough literature search using various electronic databases. We included studies that reported outcomes after peripheral femorofemoral VA-ECMO decannulation with the Manta vascular closure device. We performed a meta-analysis of proportions on outcome measures, including technical success, bleeding complications, vascular complications, wound complications, major amputation, and procedural-related deaths. RESULTS: We included seven studies with a total of 116 patients. The overall technical success of percutaneous decannulation of VA-ECMO with the Manta vascular closure device was 93.7%. The overall incidence of bleeding, vascular and wound complications was 1.7%, 13.8%, and 3.4%, respectively. No patient required lower limb amputation or died due to VA-ECMO decannulation. CONCLUSION: Percutaneous decannulation with the Manta vascular closure device is an effective and safe procedure that should be considered in suitable patients on VA-ECMO. CI - (c) 2023 International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC. FAU - Ng, Jun Jie AU - Ng JJ AD - Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore, Singapore. AD - Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. AD - SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore. FAU - Lee, Stefanie H T AU - Lee SHT AD - SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore. AD - Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. FAU - Lim, Joseph K W AU - Lim JKW AUID- ORCID: 0000-0002-2906-2550 AD - Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore, Singapore. AD - SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore. FAU - Chan, Karen K W AU - Chan KKW AD - Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore, Singapore. AD - Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. AD - SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore. FAU - Lim, Mark D S AU - Lim MDS AD - Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore, Singapore. AD - SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore. FAU - Ahmed, Mohamed A I AU - Ahmed MAI AD - Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore, Singapore. AD - SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore. FAU - Loh, Stanley E K AU - Loh SEK AD - SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore. AD - Department of Diagnostic Radiology, Woodlands Health Campus, Singapore, Singapore. FAU - Choong, Andrew M T L AU - Choong AMTL AD - Division of Vascular and Endovascular Surgery, Department of Cardiac, Thoracic and Vascular Surgery, National University Heart Centre, Singapore, Singapore. AD - Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. AD - SingVaSC, Singapore Vascular Surgical Collaborative, Singapore, Singapore. AD - Cardiovascular Research Institute, National University of Singapore, Singapore, Singapore. LA - eng PT - Journal Article PT - Meta-Analysis PT - Review PT - Systematic Review DEP - 20230510 PL - United States TA - Artif Organs JT - Artificial organs JID - 7802778 SB - IM MH - Humans MH - *Vascular Closure Devices/adverse effects MH - *Extracorporeal Membrane Oxygenation/methods MH - Shock, Cardiogenic/surgery/complications MH - Hemorrhage/etiology MH - Device Removal/adverse effects MH - Retrospective Studies MH - Treatment Outcome OTO - NOTNLM OT - ECMO OT - decannulation OT - meta-analysis OT - percutaneous OT - systematic review EDAT- 2023/05/10 06:42 MHDA- 2023/10/23 12:42 CRDT- 2023/05/10 04:03 PHST- 2023/03/22 00:00 [revised] PHST- 2022/12/27 00:00 [received] PHST- 2023/04/19 00:00 [accepted] PHST- 2023/10/23 12:42 [medline] PHST- 2023/05/10 06:42 [pubmed] PHST- 2023/05/10 04:03 [entrez] AID - 10.1111/aor.14554 [doi] PST - ppublish SO - Artif Organs. 2023 Sep;47(9):1431-1441. doi: 10.1111/aor.14554. Epub 2023 May 10.